Article
Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.
Frontiers in cellular and infection microbiology - 1 Jan 2024
Hernández-García Marta, Barbero-Herranz Raquel, Bastón-Paz Natalia, Díez-Aguilar María, López-Collazo Eduardo, Márquez-Garrido Francesc J, Hernández-Pérez José María, Baquero Fernando, Ekkelenkamp Miquel B, Fluit Ad C, Fuentes-Valverde Víctor, Moscoso Miriam, Bou Germán, Del Campo Rosa, Cantón Rafael, Avendaño-Ortiz José
Abstract excerpt
Introduction: Murepavadin is an antimicrobial peptide (AMP) in clinical development that selectively targets Pseudomonas aeruginosa LptD and whose resistance profile remains unknown. We aimed to explore genomic modifications and consequences underlying murepavadin and/or colistin susceptibility. Methods: To define genomic mechanisms underlying resistance, we performed two approaches: 1) a genome-wide association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
